Trump Administration Files Appeal
On May 28, 2025, the Court of International Trade (CIT) ruled that President Trump’s use of the International Emergency Economic Powers Act (IEEPA) to instill tariffs (known as the “fentanyl” and “reciprocal” tariffs imposed in February and April, respectively) was unauthorized.
The CIT issued the decision following two hearings and legal challenges to the Trump administration’s IEEPA tariffs. The ruling applies not just to the plaintiffs in both cases, but to all importers subject to the IEEPA duties (but not other tariffs such as Section 232 or Section 301 tariffs).
Plaintiffs in the two CIT IEEPA tariff cases have until June 18, 2025 to respond to the government’s appeal.
A.N. Deringer, Inc. will continue to closely monitor the CIT’s and federal courts actions regarding the IEEPA tariffs and will update our customers and stakeholders accordingly.
SOURCES: Roll & Harris, LLP, Wall Street Journal
Due to the rapidly changing application and modifications of duty rates, please note that Deringer is not responsible for coordinating the timing of U.S. entry and imposed tariff rates.